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The planet Earth was formed, in a molten state, some 4.5 billion 
years ago. It cooled off sufficiently 4 billion years ago to allow 
the formation of the oceans. Cyanobacteria, found in rock fossil 
records that are approximately 3.6 billion years old, provide 
the earliest evidence of life in the form of complex unicellular 
organisms. Molecular phylogeny is the tool that enables us to 
understand life in all its complexity and recognise relationships 
between organisms. In essence, using molecular techniques, 
we are able to determine the evolutionary relationships of 
living creatures. By comparing the difference in sequences of 
homologous genes encoding ribosomal RNA (16S rRNA genes 
from prokaryotic cells and 18S rRNA from eukaryotic cells) 
we can measure the evolutionary distance between species 
of organisms. Computer analysis of rRNA gene sequences 
suggests that cellular life has evolved along three major 
lineages. Two of these, Bacteria and Archaea, are exclusively 
microbial and consist of prokaryotic cells. The third lineage, 
Eukarya, not only contains unicellular organisms but also 
myriad multicellular organisms. Two important points have 
emerged from the study of molecular phylogeny: (i) unicellular 
organisms are the major and most diverse form of life; and (ii) 
eukaryotes are not of recent origin, as previously thought, but 
as ancient as the Bacteria and Archaea lineages, all of which 
have emerged from a universal ancestor. Although the human 
race may live in harmony, and is subject to colonisation with 
many different prokaryotic (e.g. bacteria) and eukaryotic (e.g. 
fungi and parasites) organisms, this harmony is shattered from 
time to time when a relatively restricted number of microbial 
species enter our body and cause pathology-infection.
Antimicrobials, developed on a mass scale from the 1940s 
onwards, brought renewed hope that, to quote the UN Surgeon 
General in his address to Congress in 1969, ‘We can close the 
book on infectious diseases’. Unfortunately, nothing could have 
been further from the truth. With the continuous emergence of 
microbes that display a vast array of antimicrobial resistance 
mechanisms, the ‘golden era’ of antimicrobials is under 
serious threat. Not only has mankind been challenged by 
multiple drug-resistant (MDR) pathogens, but the disturbing 
re-emergence of infections thought to have been controlled 
or defeated (e.g. tuberculosis) together with the emergence of 
relatively new infectious agents (e.g. Clostridium difficile, Ebola 
virus, prions) and hitherto unknown organisms (e.g. SARS-
coronavirus and metapneumovirus) is evidence that mankind 
is continually challenged by infectious entities. By the end of 
the 20th century, it was estimated that, globally, 50 million 
people die each year; of these, 20 million die as a result of 
infectious diseases.
The aims of this article are to:
•  Understand the concept of infectious disease causation
•  Elucidate host-parasite interactions and discuss the genesis of 
infectious diseases
•  Understand the complexity of bacterial interactions within 
biofilms
•  Appreciate the contribution of the molecular biology era in 
enabling us to understand and diagnose the causative agents 
of infectious diseases.
Causation of infection
The beginning of the search for microbial causes of infection 
was during the 1840s when a German anatomist Friedrich 
Henle, first hypothesised the existence of infectious agents 
that may have caused certain infectious diseases. Although 
Henle accepted that microbes (pathogens) could cause disease 
(symptomatic infection), he emphasised the fact that causation 
of infection by a pathogen with disease (infection) could not 
be simply assumed by the association of infection with a 
microbe. In 1840, as quoted by Fredricks and Relman,1 Henle 
wrote: ‘One could prove empirically that organisms were really 
effective only if one could isolate … the contagious organisms 
from the contagious fluids (from the infected host), and then 
observe the power of each separately’. While Henle pursued 
his academic endeavours at the University of Gottingen, 
Robert Koch enrolled at this Institution in 1862. It is not clear to 
what extent Henle’s ideas influenced Koch on the subsequent 
development of his postulates on how to prove the causal 
relationship between an infectious agent and its associated 
disease. The Koch’s postulates, as they have become known, 
were presented in 1890 at the 10th International Congress 
of Medicine in Berlin and state the following:2 (i) the micro-
organism occurs in every case of infection  under circumstances 
that account for both the pathological features and the clinical 
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course of the infection, (ii) the micro-organism does not occur 
in any other disease as a fortuitous and non-pathogenic 
agent, (iii) after being cultured from the diseased host and 
repeatedly grown in pure, axenic (artificial, lifeless) culture, 
the micro-organism causes the same disease in a new host, and 
(iv) the micro-organism must be recovered once again from 
pathological lesions of this new host. The fourth requirement 
was subsequently added to the Koch’s postulates. 
The key concepts in the Koch’s postulates are: (i) specificity 
of the association of a micro-organism with an infectious 
condition; (ii) biologically and scientifically plausible 
correlation of microbiological, pathological and clinical 
features; (iii) isolation of the causative micro-organism by 
culturing it on laboratory media; and (iv) reproduction of 
disease by inoculating the isolated micro-organism into a 
susceptible host. The aim of the Koch’s postulates was, by 
virtue of the criteria contained therein, to determine the 
association between micro-organisms and infection thereby 
formalising the connection between cause and effect in clinical 
medicine.
Certain limitations, pointed out by Fredricks and Relman,1 
inherent in the Koch’s postulates were already evident in 
the 1800s. Although, at the time of Koch, Vibrio cholerae was 
recovered from patients with cholera, it was also isolated from 
healthy individuals, thus defying Koch’s second postulate that 
stipulates the importance of the specificity of association of 
microbe with disease. With our increased understanding and 
elucidation of causation of infectious diseases, the limitations 
posed by the original Koch’s postulates remain frustrating. 
Scientists are still struggling with laboratory culturing of 
Mycobacterium leprae – the cause of leprosy. Not being able 
to adequately isolate M. leprae in pure cultures impedes the 
fulfilment of Koch’s third postulate. Other examples in which 
one or more of the Koch’s postulates are not fulfilled include:1 
(i) organisms such as Plasmodium falciparum and herpes simplex 
virus or other viruses cannot be grown in cell-free, lifeless 
cultures, yet their pathogenicity is unequivocal; (ii) organisms 
that do not cause disease in carriers (e.g. Neisseria meningitidis) 
or those causing sub-clinical infection (e.g. Mycobacterium 
tuberculosis); (iii) organisms capable of toxin production causing 
distant injury from the infecting site or autoimmune reactions; 
(iv) organisms requiring co-infection with bacteriophages, 
e.g. Corynebacterium diphtheriae to acquire genes that encode 
for toxins that cause clinical disease; (v) viruses that require 
co-infection with another virus before causing infection, e.g. 
hepatitis D with B; (vi) organisms such as HIV that cannot 
produce typical disease in other hosts; and (vii) other host 
(including genetic) and environmental factors that are not 
taken into consideration. 
Koch’s postulates were used extensively and successfully 
as an experimental methodology to describe many microbes 
and the diseases they cause in medical microbiology. However, 
these criteria did break down and had to be modified with the 
discovery of viruses and the birth of virology that occurred 
during 1886 - 1903. Viruses, as we understand them today are 
at the threshold of life in their design and function. They are 
non-cellular packages of protein and genetic material lacking 
any physiological material of their own thus making them 
obligate intracellular parasites and completely dependent on 
a host for survival. The emergence of virology, as a science, 
led to the need to accommodate the problem of proving 
disease causation by viruses. Rivers, in 1937, proposed 
his own postulates:1,3 (i) a virus associated with a disease 
should be present with a high degree of regularity; and (ii) 
the virus associated with an ill, infected, host must not be a 
fortuitous finding but be the actual cause of disease. Rivers 
made provision for the concept of a viral carrier state with 
the abandonment of the need to grow pathogenic viruses in 
media or cell culture. In addition, in order to establish the link 
between a virus and a specific disease, the pathogenic virus 
should be associated with specific pathological lesions during 
infection. Inoculation of infected material into susceptible hosts 
should also produce disease, and/or the production of specific 
antiviral antibodies, with some regularity in comparison to 
appropriate controls. 
In 1957, Huebner proposed the introduction of 
immunological criteria, such as the development of specific 
antibodies to epitopes on an infectious agent or the prevention 
of the infection by a specific vaccine and, in addition, 
emphasised the importance of taking epidemiological criteria 
into account when attempting to determine the relationship 
between viruses and disease.1,4 Hill in 1965 eloquently 
described a number of epidemiological criteria that could be 
useful, in conjunction with the many revisions of the Koch’s 
postulates, to distinguish between disease causation and 
association.5  
A further set of criteria for causation was developed by 
Evans in 1976.6,7 These were based on information that could be 
obtained using modern techniques, a greater understanding of 
the pathogenesis host-microbe interactions, and an insightful 
recognition of the limitations of the original Koch’s postulates. 
The Evans criteria, as listed by Fredricks and Relman,1 are:
1. The prevalence of a disease should be significantly higher 
in those exposed to the putative cause than in control cases 
where there is no exposure.
2. Exposure to the putative cause should present more 
commonly in those with disease than in controls without the 
diseases when all risk factors are held constant.
3. Incidence of the disease should be significantly higher 
in those exposed to the putative cause than in those not so 
exposed, as shown in prospective studies.
4. Temporally, the disease should follow exposure to the 
putative agent with a distribution of incubation periods on a 
bell-shaped curve.
5. A spectrum of host responses should follow exposure to 
the putative agent along a biological gradient from mild to 
severe.
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6.  A measurable host response following exposure to the 
putative cause should regularly appear in those lacking this 
exposure or should increase in magnitude if present before the 
exposure.
7. Experimental reproduction of the disease should occur in 
higher incidence in animals or humans appropriately exposed 
to the putative cause than those not so exposed; this exposure 
may be deliberate in volunteers, experimentally induced in 
the laboratory, or demonstrated in a controlled regulation of 
natural exposure.
8. Elimination or modification of the putative cause or of the 
vector carrying it should decrease the incidence of disease.
9.  Prevention or modification of the host’s immune response 
on exposure to the putative cause should decrease or eliminate 
the disease, and
10. It should make biological and epidemiological sense.
The study of emerging or new viral diseases is complex 
and includes interpretation of the interaction between three 
important factors: the environment, the microbe and the 
host. Once epidemiological and serological criteria have 
been met, new viral diseases are further described using 
classic laboratory methods of virus isolation, culture in cell-
containing media, and sequence-based molecular techniques. 
Using these various epidemiological criteria and laboratory 
techniques, many new viruses have been described since the 
1970s including Marburg virus in 1976, Ebola virus in 1977, 
and chronic viral diseases like hepatitis C in 1989. AIDS is 
an excellent example of the emergence of a new viral disease 
that occurred when changes in the ancestral simian HIV virus 
genome strain occurred after exposure to a new host (Homo 
sapiens). An infection that was originally zoonotic eventually 
adapted and established itself in human populations.
Where a micro-organism cannot be easily isolated in the 
laboratory, and with the advent of the molecular biology era, 
sequence-based methods for the identification of microbial 
pathogens can provide evidence of disease causation. In what 
follows, HIV is used as an example, in guidelines that are 
cited by Fredricks and Relman1 for the establishment of causal 
relationships between a microbe and a disease:
1. A nucleic acid sequence belonging to a putative pathogen 
(e.g. HIV) should be present in most cases of an infectious 
disease (e.g. AIDS as the end-stage of HIV infection).
2. Fewer, or no, copy numbers of pathogen-associated nucleic 
acid sequences should occur in hosts and tissues without 
disease (if the host is truly HIV negative, then there should be 
no HIV-associated nucleic acid sequences that are detectable).
3. Copy number of pathogen-associated nucleic acid 
sequences should decrease or become undetectable with 
treatment or resolution of the disease (on appropriate highly 
active antiretroviral therapy (HAART) regimens, successful 
treatment is indicated by serial HIV viral load monitoring until 
it reaches undetectable levels).
4. When sequence detection predates disease, or sequence 
number correlates with the severity of disease or pathology, 
the sequence-based association is more likely to be a causal 
relationship (e.g. HIV may be detected by HIV RNA-PCR in 
a patient who is completely asymptomatic and unaware of 
his/her infection, i.e. the presence of the sequence predates 
symptomatic disease, or the number of HIV copies that 
are detected increase with disease progression if no or an 
unsuccessful HAART is given).
5. When phenotypes (e.g. pathology, microbial morphology, 
and clinical features of HIV infection) are predicted by 
sequence-based phylogenetic relationships, the meaningfulness 
of the sequence is enhanced.
6. Tissue-sequence correlates should be sought at cellular 
levels (e.g. if there is tropism of HIV for cells bearing CD4 
receptors it is a reasonable expectation to note the pathological 
effects of HIV on cells bearing such receptors).
7. Sequence-based forms of evidence should be reproducible 
(if testing for HIV nucleic acid sequences on the same patient’s 
blood sample is performed by two independent researchers or 
sites, the results should be similar in what they reflect).
The pathogenesis of infectious diseases
All microbes causing infectious diseases are subjected to 
a series of gruelling challenges, if they are to succeed. Put 
simply, these are a sequence of bacterial (prokaryotic) – host 
(usually eukaryotic) cell interactions. Firstly, pathogenic 
micro-organisms, e.g. bacteria, usually reside and multiply 
in an environment that favours their survival, replication 
and existence. All pathogenic (disease-causing) micro-
organisms must identify a route of transmission from their 
reservoir (animal, human, plants, water, soil, air) to the hosts 
they will infect. Once the micro-organism is successfully 
transmitted, its first challenge is to adhere to the epithelial 
(mucosal) surface for which the microbe has the greatest 
tropism. Microbial adhesion is the first and most critical 
process in infection. Adhesion of a micro-organism to a 
mucosal cell surface or a target site can be nonspecific (as 
a consequence of hydrophobicity, van der Waal’s forces of 
attraction, formation of extracellular slime) or highly specific 
(involving a microbe-specific host receptor interaction, e.g. 
the attachment of the bacterial toxin of the cholera-causing 
organism, Vibrio cholerae, to GM1 ganglioside receptors 
present on small intestinal epithelial cells). Adhesion may 
be followed by invasion of an organism which results in the 
passage of a bacterium through other cell populations in 
the epithelia (e.g. M cells in the gastrointestinal tract) or by 
damage of the epithelial layer.  Within the host, multiplication 
of the organism can then occur and in so doing will evoke 
immune responses from the host. The host mucosal surface is 
constantly on guard against microbial invasion and produces 
an array of antimicrobial defences that microbes have to deal 
with.  These defences include the production of antibacterial 
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peptides, metal-chelating compounds, destructive enzymes 
such as lysozyme, and mucosal and secretory IgA and other 
antibodies.  Collectively, all of these constitute what has 
become the highly specialised science of mucosal immunity. 
For a microbe to survive, it is essential that it is armed with 
mechanisms to overcome or evade protective host responses.  
Pathology caused by microbial infection is usually due to either 
microbial factors (e.g. release from bacterial cells of exotoxins) 
or to the overproduction or hyper-responsiveness of host 
factors – predominantly cytokines – produced by the host as 
a defence against infection. The ability of a microbe to adhere, 
invade, evade host defences and cause tissue damage is due 
to its ability to produce virulence factors.  These include: (i) 
adhesions, which promote microbial adherence to host tissues; 
(ii) invasins, which are responsible for tissue invasion; (iii) 
impedins, molecules which allow microbes to overcome host 
mechanisms; (iv) aggressins, factors which promote damage to 
host cells and tissues; and (v) immunomodulatory microbial 
components. Finally, as an infectious microbe survives by 
spreading and amplifying itself from host to host, it must be 
able to exit from the host and encounter another uninfected 
host to start the infectious cycle anew. Alternatively, the 
microbe must return to, and persist in, its reservoir.
Let us divert the discussion for a moment from bacteria to 
viruses and consider the applicability of the above concepts 
to Marburg virus. Like its closely related species, Ebola, 
it belongs to the family Filoviridae. The genus Filovirus is 
separated into two distinct species, Marburg and Ebola, which 
differ significantly in their glycoprotein (GP) genes. The 
divergence between the two species of Filovirus implies that 
both have a common ancient ancestral origin and they have 
slowly (perhaps over a period of five millennia) co-evolved 
with their as yet unconfirmed natural hosts. The reservoir 
of both Marburg and Ebola viruses, though speculated and 
much debated, remains unknown.  Marburg virus is probably 
a zoonotic pathogen but when primates including man are 
infected with this microbe, it can cause devastating disease 
as a consequence of its formidable virulence. The agent is 
transmitted to a new host as a consequence of the latter coming 
into contact with virus-contaminated body fluids that have 
been excreted by the initial host infected with this virus.
The pathogenetic sequence of infection, as described by and 
summarised from Bray,8 involves the following steps:
1. Initial infection of macrophages, dendritic cells and other 
cells of the mononuclear phagocytic system (MPS), probably 
in regional lymph nodes occurs. The cell surface receptor of 
filoviruses has not been identified but electron microscopy 
studies suggest that filoviruses bind to a broad range of cells 
and enter the cell through endocytosis. Intracellular viral 
replication is accompanied by cytoplasmic vesiculation and 
mitochondrial swelling, breakdown of organelles, and terminal 
cytoplasmic rarification. 
2. Replication of virus is accompanied by suppression of 
interferon (INF)-α/β which allows rapid local and systemic 
dissemination.
3. MPS cells that migrate to other tissues release free virions 
into the lymphatics or bloodstream, resulting in systemic 
dissemination, infecting fixed tissue macrophages in the liver, 
spleen and other tissues around the body.
4. Virions released from the above-mentioned cells infect, 
among others, hepatocytes, adrenal cortical cells, fibroblasts, 
and endothelial cells in adjacent blood vessels.
5. Infected macrophages, once activated, release large 
quantities of cytokines and chemokines (tumour necrosis factor 
(TNF)-α, monocyte chemotactic protein (MCP)-1, macrophage 
inflammatory protein (MIP)-1α, etc.).
6. Increased permeability of the duodenum, leakage of 
macromolecules, expression of endothelial cell surface adhesion 
and procoagulant molecules, together with tissue destruction, 
result in exposure of underlying collagen and release of tissue 
factor. This leads to disseminated intravascular coagulopathy 
(DIC), platelet dysfunction and progressive hepatic failure.
7. Massive cytolysis, fluid shifts, effects of cytokines, 
interstitial haemorrhage and tissue ischaemia (from diffuse 
obstruction of capillary blood flow by masses of virions and 
microthrombi), all contribute to mortality.
Marburg virus is associated with an exceptionally high 
mortality (80 - 90%) of all infected and microbiologically 
confirmed clinical cases. During the course of clinical illness, 
contact with blood and body fluids from the infected host is 
the main mechanism whereby the virus leaves its first host, 
and infects another anew. During interepidemic periods, the 
virus returns back to its elusive reservoir/s.
Viewing infection through a biofilm
The concept of microbes, e.g. bacteria, living in biofilms, was 
first described by the great Dutch microscopist, Antoni van 
Leeuwenhoek, in 1863. Using a single-lens microscope he 
described ‘animalcules’ in the mouths and on teeth of humans. 
Quoted in Henderson et al.,9 van Leeuwenhoek wrote:  ‘… But 
what if I should tell such people in future that there are more 
animals in the scum on the teeth (dental plaque) in a man’s 
mouth, than there are men in the whole kingdom?’.
It could be argued that for the last 50 years we have 
devoted most of our efforts in studying the minor bacterial 
phenotype (planktonic cells), ignoring the major phenotype 
(biofilm-embedded sessile cells) predominant in natural and 
pathogenic ecosystems. A biofilm is, in essence, an assemblage 
of microbial cells, irreversibly associated with a surface, 
and enclosed in a matrix of mainly, but not exclusively, 
polysaccharide material. Thus the long-held view that bacteria 
are a simple, primitive, version of the evolutionarily superior 
eukaryotic cell, acting as a unicellular automaton, is no longer 
correct. As our understanding of bacteria accumulates, it is 
now appreciated that they are complex, craftily adapted and 
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highly adaptable micro-organisms which can respond to 
their environment in myriad, varied ways. The concept of a 
consortium of cells living within a biofilm matrix is indeed 
a form of multicellularity, giving bacteria huge survival 
advantages that eukaryotic, multicellular organisms enjoy. 
Biofilm multicellularity results in better bacterial defences 
against the host. Nutrient depletion in the sessile cells that are 
most deeply embedded in a biofilm creates zones of altered 
metabolic activity. A distinction needs to be made between 
sessile (inner) and planktonic (outer) biofilm cells. Sessile 
cells are small, tightly adherent and relatively metabolically 
inactive cells that are found deeply embedded at the bottom 
of a biofilm and that adhere tightly on a variety of surfaces: 
In natural aquatic systems these could be rocks in a river, in 
industrial systems these could be water tanks or pipes and 
in the medical setting these surfaces might include medical 
devices (e.g. cardiac pacemakers, prostheses, central venous 
catheters, etc.) and living tissues (e.g. the lungs in cystic 
fibrosis, gallstones in cholecystitis, prostate in prostatitis, etc.). 
As the outer (planktonic) cells of a biofilm absorb damage 
(including the onslaught from antibiotics), this allows inner 
layers of biofilm cells to buy more time to initiate a stress 
response.  A higher number of ‘persister’ cells are present in 
the biofilm. Bacterial biofilms confer physiological adaptive 
antimicrobial resistance to the bacterial cells contained therein: 
This may be due to one or a combination of the following 
factors: (i) antimicrobial neutralisation; (ii) nutrient-limited 
physiology; and (iii) penetration failure. Furthermore, the 
metabolic inactivity of sessile bacterial cells makes it difficult 
for antibacterial agents to function effectively. Although 
biofilms can be dealt with using antibiotics, 1 000 - 1 500 times 
higher doses are required to kill biofilm versus planktonic 
cells. In much the same way as multicellular organisms are 
dependent on intercellular communication or signalling for 
their survival, it is now appreciated and proven that bacteria 
do signal to each other. The term ‘quorum sensing’ refers to 
the ability of bacteria within a population, e.g. a biofilm, to 
determine their cell density and consequently, as required, 
switch on (or off) the expression of particular genes or operons 
(sets of genes) that favour their survival. It could well be that 
when a bacterial population reaches a critical cell density 
(i.e. it  is quorate) census taking by bacteria is a virulence 
mechanism to allow them to increase in numbers, without 
switching on virulence genes that might alert the host to their 
presence. Quorum sensing is not the only example of the 
complex interactions bacteria have with their environment. 
Prokaryotic-eukaryotic communication also occurs: bacteria 
can respond to signals from eukaryotic host cells as well 
react to direct cell-to-cell contact with host cells. Bacteria are 
responsive to a wide array of mammalian mediator molecules 
such as serotonin, catecholamines, insulin and cytokines 
including interleukin (IL)-1, IL-2, TNF, and transforming 
growth factor (TGF). Bacteria can themselves produce a 
variety of immunoregulatory molecules that result in the 
release of cytokines that are not only key cell-to-cell regulatory 
molecules in multicellular organisms, but also control immune 
responses (both innate and acquired) in vertebrates including 
humans. Macrophages and other cells of the host’s immune 
system attempt to penetrate the biofilm but become trapped. 
In so doing these very same cells release cytokines that cause 
damage in the host.
The renewed understanding of 
infectious diseases – the molecular 
biology era
Molecular biology techniques have enabled our understanding 
of infection to progress far beyond the boundaries that we 
thought we had reached. Understanding cell-to-cell interactions 
at the level of molecules, having techniques that enable us to 
amplify genes unique to specific microbial cells, our ability to 
perform DNA fingerprinting of organisms to establish their 
clonality or relatedness, the ability of characterising entire 
genomes of microbes as well as their specific virulence factors 
all have radically transformed the pathogenetic understanding, 
molecular epidemiology, diagnosis, and approaches to 
treatment of infectious diseases. 
Conclusion
Microbes are not ‘just microbes’. As we are only beginning 
to grasp the extraordinary nature of what we previously 
considered ‘simple’ organisms, we are humbled by the 
microbial world. The sometimes uneasy relationship between 
man and microbe, that may lead to devastating disease and 
death of millions of humans each year, is a sober reminder that 
mankind is in charge of its destiny only to a limited degree. 
Despite advances in our knowledge of infectious diseases and 
the development of an array of novel therapeutic strategies, the 
ability of the microbial world to adapt, develop new strategies 
for survival, develop new virulence traits, express novel 
mechanisms for antimicrobial resistance is a poignant reminder 
that man is just Homo sapiens, one of the many forms of life on 
our earth. We are so heavily colonised by microbes that 90% of 
the human body, purely on the basis of cell numbers, consists 
of bacteria. By understanding this concept, we should reflect on 
the miraculous, diverse and complex nature of our universe.
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